Headquarters: Hangzhou, Zhejiang, China
Employee Number: 51-100
Total Funding: $124 M
Founded Date: 01.01.2015
Technology: Immunotherapy
Estimated Revenue: $1M to $10M
Industry: Early Drug Development
Funding Status: M&A